CMP: 12

Jagsonpal Pharmaceuticals develops and manufactures bulk drugs and pharmaceutical formulations.

Jagsonpal Pharma is a 33 Crore penny cap stock. Its currently trading at a P/E of 6 with pretty high dividend yields of almost 4% in the last 12 months. Minimal liability. Revenues have grown slowly, but steadily from 130 Crores to 160 Crores in the last 5 years. Profits have risen from less than 3 Crores to over 7 Crores in the same period. NPM has grown from little over 2% to well over 4% over the last 5 years. There are very few good penny stocks in pharma space. Buy and hold for long term gains.